Literature DB >> 24162065

Trinuclear heterometallic Cu(II)-Mn(II) complexes of a salen type Schiff base ligand: anion dependent variation of phenoxido bridging angles and magnetic coupling.

Piya Seth1, Soumavo Ghosh, Albert Figuerola, Asutosh Ghosh.   

Abstract

Five new trinuclear heterometallic Cu(II)-Mn(II) complexes [(CuL)2Mn(O2CPh)2] (1), [(CuL)2Mn(N3)2] (2), [(CuL)2Mn(NCO)2] (3), [(CuL)2Mn(NO3)2] (4) and [(CuL)2Mn(Sal)2]·CH2Cl2 (5) have been synthesized with the di-Schiff base ligand H2L (where H2L = N,N'-bis(salicylidene)-1,3-propanediamine and Sal = salicylate). These complexes with different anionic co-ligands have been synthesized to attain a large variation in phenoxido bridging angles and to investigate its consequence on magnetic properties. Single crystal X-ray diffraction analyses reveal that complexes 1, 2, 4 and 5 are linear, whereas 3 has an angular geometry. Variable temperature magnetic susceptibility measurements suggest that all five complexes possess an overall antiferromagnetic interaction between Cu(II) and Mn(II) ions, which results in a final ferrimagnetic ground state with spin 3/2 in the Cu(II)-Mn(II)-Cu(II) trinuclear structure. The weakest antiferromagnetic interaction (J(Cu-Mn) = -7.0 cm(-1)) is observed for 2 having the lowest value of the Cu-O-Mn angle (92.0°), while the strongest antiferromagnetic interaction (J(Cu-Mn) = -26.5 cm(-1)) is observed for 3 having the largest Cu-O-Mn angle (101.4°). Complexes 1, 4 and 5 show average Cu-O-Mn angles of 98.2°, 97.6° and 97.7°, respectively, that lead to intermediate antiferromagnetic interactions (J(Cu-Mn) = -9.6, -9.7, -9.3 cm(-1) respectively).

Entities:  

Year:  2013        PMID: 24162065     DOI: 10.1039/c3dt52012a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  Four rare structurally characterized hetero-pentanuclear [Zn4Ln] bis(salamo)-type complexes: syntheses, crystal structures and spectroscopic properties.

Authors:  Lu-Mei Pu; Lan Wang; Xiao-Yan Li; Yin-Xia Sun; Quan-Peng Kang; Hai-Tao Long; Wei-Bing Xu; Wen-Kui Dong
Journal:  RSC Adv       Date:  2019-11-15       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.